Barans, Sam https://orcid.org/0000-0002-9878-5955
Saavedra, Justine L.
Lardier, David T.
Tohen, Mauricio
Lenroot, Rhoshel
Bustillo, Juan
Halperin, Dawn
Friedman, Bess
Loewy, Rachel
Murray-Krezan, Cristina
McIver, Stephanie
Crisanti, Annette S.
Funding for this research was provided by:
National Institute of Nursing Research (R25CA247677)
Article History
Received: 3 April 2024
Accepted: 4 December 2024
First Online: 5 January 2025
Declarations
:
: Dr. Tohen reports that he is a former full-time employee of Eli Lilly and Company (1997–2008), as is his spouse (1998–2013). He also reports serving as a consultant for Abbott Laboratories, Alexza Pharmaceuticals, Alkermes, Allergan, AstraZeneca, Bristol Myers Squibb, Elan, Eli Lilly and Company, Forest Pharmaceuticals, Gedeon Richter, GlaxoSmithKline, Intra-Cellular Therapies, Johnson & Johnson, Lundbeck, Merck & Co., Minerva Neurosciences, Otsuka, Pamlab, Roche, Sunovion, Teva Pharmaceuticals, and Wyeth. Dr. Bustillo reports receipt of royalties from UpToDate. The other authors report no financial relationships with commercial interests.